FDA has delayed its decision on Gilead's (GILD) Truvada to prevent HIV -Bloomberg
Tweet Send to a FriendGet Alerts GILD Hot Sheet
Down)
Trade GILD Now!
Bloomberg reporting FDA has delayed its decision on Gilead's (Nasdaq: GILD) Truvada to prevent HIV
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- EMA Approves MAA for Gilead's (GILD) Sofosbuvir
- European Medicines Agency Validates Gilead’s Marketing Application for Sofosbuvir for the Treatment of Hepatitis C
- KKR looking at Saks (SKS) investment, may merge with Nieman Marcus - Bloomberg
Create E-mail Alert Related Categories
FDA, Rumors
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
